A real world study of off-label use of domestically manufactured tenecteplase in acute ischemic stroke based on inverse probability weighting method based on propensity score

Zhong Yutong; Han Xiaoyan; Zhi Chumin; Li Youjia

doi:10.3969/j.issn.1009-816x.2025.06.004

Prevention and Treatment of Cardio-Cerebral-Vascular Disease, Volume. 25, Issue 6, 12(2025)

A real world study of off-label use of domestically manufactured tenecteplase in acute ischemic stroke based on inverse probability weighting method based on propensity score

Zhong Yutong¹, Han Xiaoyan², Zhi Chumin¹, and Li Youjia^2、*

Author Affiliations

¹The First Clinical College of Medicine, Guangdong Medical University, Zhanjiang 524023, China

²Department of Neurology, the First People's Hospital of Zhaoqing, Guangdong Medical University, Zhaoqing 526000, China

show less

Abstract Get PDF(in Chinese)

Figures & Tables(0)

Tools

Get Citation

Copy Citation Text

Zhong Yutong, Han Xiaoyan, Zhi Chumin, Li Youjia. A real world study of off-label use of domestically manufactured tenecteplase in acute ischemic stroke based on inverse probability weighting method based on propensity score[J]. Prevention and Treatment of Cardio-Cerebral-Vascular Disease, 2025, 25(6): 12

Download Citation

EndNote(RIS)BibTex Plain Text

Set citation alerts for article

Save article for my favorites

Paper Information

Category:

Received: Sep. 14, 2024

Accepted: Aug. 25, 2025

Published Online: Aug. 25, 2025

The Author Email: Li Youjia (18902368836@189.cn)

DOI:10.3969/j.issn.1009-816x.2025.06.004

Topics